Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease
Luc de Chaisemartin(Inserm), Marie‐Agnès Dragon‐Durey(Centre de Recherche des Cordeliers), Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Tchao Méatchi(Assistance Publique – Hôpitaux de Paris), Georgia Malamut(Délégation Paris 5), D. Rault(Assistance Publique – Hôpitaux de Paris), Frédérique Hosking(Assistance Publique – Hôpitaux de Paris), Fahima Fernani-Oukil(Assistance Publique – Hôpitaux de Paris), Fabienne Bellery(Assistance Publique – Hôpitaux de Paris)
Cited by 17
Related Papers
European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten‐related disorders
|United European Gastroenterology Journal|2019|987
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605